Operating Company Healthcare

MedImpact

San Diego, California, United States

Independent health solutions and pharmacy benefit management company serving commercial health plans, government programs, self-insured employers, and consumers. Its offerings include PBM services, clinical programs, health technology, and employer health and risk-management solutions.

Focus Areas
Pharmacy Benefit Management (PBM), Clinical pharmacy services, Health risk and care management

Tracked deals

3

3 tracked deals across 2024-2026.

Recent pace

2

2 tracked deals announced in the last 12 months.

Deal mix

Buyout

2 buyout · 1 divestiture

MedImpact Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for MedImpact. 1 2024 ~2 est. 2 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    MedImpact Holdings, Inc.
    Target
    MHW Benefit Partners (formerly SRS Benefit Partners), MSL Captive Solutions
    Type
    Buyout

    MedImpact Holdings, Inc. announced the acquisition of two employer insurance and risk management firms: MHW Benefit Partners (formerly SRS Benefit Partners) and MSL Captive Solutions. The deals expand MedImpact’s portfolio of modular care and coverage options for small and mid-sized employers by adding captive program formation and medical stop-loss capabilities.

  • February 2, 2026
    Buyer
    MedImpact Healthcare Systems, Inc.
    Target
    Sav-Rx (Sav-Rx Prescription Services)
    Type
    Buyout

    MedImpact Healthcare Systems has completed the acquisition of Sav-Rx, a pharmacy benefit manager with more than five decades of experience serving organized labor. The deal expands MedImpact's scale, specialized PBM expertise, and health solutions portfolio while allowing Sav-Rx to operate independently under its existing leadership.

  • Buyer
    MedImpact Healthcare Systems, Inc.
    Target
    Elixir Solutions
    Seller
    Rite Aid Corporation

    MedImpact Healthcare Systems has completed the acquisition of Rite Aid’s Elixir Solutions business for about $576.5 million. The deal expands MedImpact’s clinical, technology, health risk management and consumer empowerment capabilities as part of its reinvestment strategy and strengthens its position as an independent provider of health solutions and PBM services.

Related Acquisition Pages

Selling a company? Get in front of buyers like MedImpact

Turn tracked acquisition activity into an outreach-ready buyer list.